NetworkNewsBreaks

WednesdaySep 23, 2020 10:49 am

NetworkNewsBreaks – Ampco-Pittsburgh Corp.’s (NYSE: AP) Rights Offering Expires, $19.3M Raised

Ampco-Pittsburgh (NYSE: AP) recently reported that its previously announced rights offering expired on Friday, Sept. 18, 2020, at 5 p.m. ET. Consequently, these rights are no longer exercisable. The company also announced that the offering was 97% subscribed, with subscriptions obtained through the offering totaling approximately 12.3 million units. The total amount raised through the offering reached approximately $19.3 million in gross proceeds. The results of the rights offering and the aggregate gross proceeds of the rights offering are subject to finalization and verification by its subscription agent with DTC. In addition, Ampco-Pittsburgh announced that it expects the closing of…

Continue Reading

WednesdaySep 23, 2020 10:21 am

NetworkNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) Announces Successful BolaWrap(R) Deployment in Safe Restraint of Georgia Suspect

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced a successful deployment of the BolaWrap by LaGrange Police Department in Georgia. The Sept. 11 domestic violence encounter was captured on an officer’s body-worn camera and can be viewed at https://nnw.fm/RqUUi. According to the update, company executives will be hosting a webcast at 4:30 p.m. ET this afternoon to review the bodycam footage and discuss field uses of BolaWrap. “After seeing the BolaWrap demonstration in-person, we knew this device could save lives,” said LaGrange Police Department Chief of Police Lou Dekmar, who is the former president of the…

Continue Reading

WednesdaySep 23, 2020 10:06 am

NetworkNewsBreaks – Cannabis Global Inc. (CBGL) Announces Amazon Launch of Hemp You Can Feel(TM) Alcohol Substitute Cocktail Mixers

Cannabis Global (OTC: CBGL), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced that its Hemp You Can Feel(TM) hemp-based alcohol substitute cocktail mixers are now live for sale on Amazon.com and Amazon Prime. These newly launched products are in addition to the already available Hemp You Can Feel Coffee pods. "Our in-house research suggests these mixers have tremendous home-run potential as a popular product line," said Cannabis Global CEO Arman Tabatabaei in the press release. "Almost universally, the feeling of having a cocktail is desirable, but the collateral consequences of chronic alcohol consumption are…

Continue Reading

WednesdaySep 23, 2020 9:45 am

NetworkNewsBreaks – Predictive Oncology (NASDAQ: POAI) Granted License for Additional 71 Unique Ovarian Cancer Cell Lines

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced that TumorGenesis, a division of the company, has received a license for an additional 71 unique ovarian cancer call lines. The licensing comes from England-based Ximbio, the largest nonprofit in the world dedicated to life science reagents. TumorGenesis now has a total of 96 unique patient-derived ovarian cancer cell lines. Research such as that conducted by TumorGenesis is  the foundation of preclinical research and development. “It is remarkable that the UK cancer researchers using the same media mixes now…

Continue Reading

TuesdaySep 22, 2020 5:03 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP), Sub-Licensee Partner Advancing Lead Drug Candidate in First-Ever Phase 1 and Phase 2 Clinical Trials

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, is advancing its leading drug candidate, Berubicin, to move forward with clinical trials in Poland. This move comes after sub-licensee WPD Pharmaceuticals Inc. has identified a contract research organization — Worldwide Clinical Trials — to coordinate and supervise Phase 1 and Phase 2 trials in the European country (http://nnw.fm/zOId7). A recent article discussing this reads, “Berubicin is proposed for the treatment of glioblastoma multiforme (‘GBM’), an aggressive and incurable form of brain cancer. Berubicin…

Continue Reading

TuesdaySep 22, 2020 4:14 pm

NetworkNewsBreaks – Mobius Interactive Ltd. CEO ‘Betting on the Growth of eSports’

Mobius Interactive’s CEO Lynn Pearce authored the feature article, “The Rise of eSports,” in the most recent issue of “Infinity Gaming” (https://www.nnw.fm/kREPi). Pearce, a data-driven, strategic brand marketer with more than 15 years of proven success in the global gaming industry, focused the article on the growing exposure and popularity of eSports in the wake of COVID-19 and the resulting forced closure of traditional sports. In the piece, Pearce indicated that there will be 2.7 billion gamers worldwide with 2.5 billion playing on mobile, 1.3 billion on PC and 0.8 billion on console by the end of this year. The…

Continue Reading

TuesdaySep 22, 2020 1:34 pm

NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Plans for Name Change, Another Step in Building Strong Brand

Grey Cloak Tech (OTC: GRCK), engaged in proprietary development of natural plant-based formulations, sales and distribution of cardiovascular and neuro products, today announced that it has filed a Schedule 14C to notify shareholders of a name change to Healthy Extracts Inc. According to the update, the name change is part of the company’s corporate strategy that aligns science-based, proprietary exclusive products and intellectual properties (“IPs”) and better reflects its focus. The trading symbol will also change to one yet to be determined. “We are excited to announce the filing of our name change from Grey Cloak Tech to Healthy Extracts…

Continue Reading

TuesdaySep 22, 2020 12:45 pm

NetworkNewsBreaks – InvestorBrandNetwork Podcast Series Tops 400 Total Episodes

InvestorBrandNetwork (“IBN”), an innovative corporate communications agency and diversified content distributor, has now released more than 400 unique podcast episodes through the IBN Podcast Series. Episodes are published on multiple syndicated platforms, including Apple Podcasts, Google Podcasts, iHeartRadio, Spotify, Stitcher, TuneIn, Bullhorn and others. IBN serves more than 500 clients through its unique interconnected network, which includes 50-plus brands. Each brand focuses on a specific market segment. In addition to that network, IBN works with more than 5,000 syndication partners and 50-plus event partners to provide the widest dissemination of news and information possible. Currently, IBN is delivering on a series of…

Continue Reading

TuesdaySep 22, 2020 12:31 pm

NetworkNewsBreaks – IDEAYA Biosciences Inc. (NASDAQ: IDYA) Announces ‘Transformational’ Second Quarter

IDEAYA Biosciences (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, recently provided a business update and announced financial results for the second quarter ended June 30, 2020. "This quarter was transformational for IDEAYA. We have cash runway into 2024, with quarter-end cash, cash equivalents and marketable securities of $172.0 million supplemented by $127.5 million aggregate gross proceeds received subsequently, including $100 million non-dilutive upfront cash and $20 million private placement equity investment from GSK,” said Yujiro S. Hata, CEO and president of IDEAYA Biosciences, in the press release. “In addition, through our…

Continue Reading

TuesdaySep 22, 2020 12:12 pm

NetworkNewsBreaks – CB Scientific Inc. (CBSC) Completes Asset Purchase Agreement, Focuses on ECG Monitoring Business

CB Scientific (OTC: CBSC), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, has completed the acquisition of Prevent Health Care International Corp., a private company located in British Columbia. The acquisition included PHCIC’s medical technology products developed to date, intellectual property, manufacturing expertise and patents. CB Scientific also acquired all information and knowledge available to promote, market and sell PHCIC’s product worldwide, excluding Australia. In addition, CBSC has acquired the subsidiaries of PHCIC, including My-Cardia USA Inc. and related businesses. Following the acquisition, CBSC assembled a core management team to continue the operation of…

Continue Reading